Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Files An 8-K Results of Operations and Financial Condition

0

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Files An 8-K Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition.

On July 27, 2017,we issued a press release reporting our financial results for the quarter ended June 30, 2017. This press release has been furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.

The information under this Item 2.02 and Exhibit 99.1 hereto is being furnished and shall not be deemed “filed” for the purposes of Section18 of the Securities Exchange Act of 1934, as amended, or the Exchange Act, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 2.02 Financial Statements and Exhibits.

(d) Exhibits.

Number

Description

99.1

Press release of Tandem Diabetes Care, Inc. dated July 27, 2017.


TANDEM DIABETES CARE INC Exhibit
EX-99.1 2 tndm-ex991_6.htm EX-99.1 EARNINGS RELEASE tndm-ex991_6.htm Exhibit 99.1 Media Contact: Steve Sabicer 714-907-6264 [email protected]   Investor Contact: Susan Morrison 858-366-6900 x7005 [email protected]   FOR IMMEDIATE RELEASE Tandem Diabetes Care Reports Second Quarter 2017 Financial Results San Diego,…
To view the full exhibit click here

About Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

Tandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump’s cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.